Withdrawn

Hydroxychloroquine plus azithromycin: a potential interest in reducing in-hospital morbidity due to COVID-19 pneumonia (HI-ZY-COVID)?

Benjamin Davido, Thibaud Lansaman, Christine Lawrence, Jean-Claude Alvarez, Frédérique Bouchand, Pierre Moine, Véronique Perronne, Aurelie Le Gal, Djillali Annane, Christian Perronne, Pierre De Truchis on behalf of the COVID-19 RPC Team
doi: https://doi.org/10.1101/2020.05.05.20088757

Article usage

Article usage: May 2020 to November 2024

AbstractPdf
May 202077148111496
Jun 202075636703
Jul 202029113425
Aug 202021501751
Sep 20201446976
Oct 20201240725
Nov 2020926645
Dec 20201601669
Jan 20211079575
Feb 20211115384
Mar 2021794433
Apr 2021593573
May 2021648826
Jun 2021511440
Jul 2021395196
Aug 2021397297
Sep 2021447228
Oct 2021305187
Nov 2021516192
Dec 2021497172
Jan 2022708229
Feb 2022310367
Mar 2022190126
Apr 2022196117
May 2022211114
Jun 202221081
Jul 202217479
Aug 202214472
Sep 202217263
Oct 202221981
Nov 202219970
Dec 202214843
Jan 20239648
Feb 202311549
Mar 202323267
Apr 202310560
May 20236945
Jun 20237722
Jul 20234730
Aug 20237540
Sep 20238731
Oct 20236943
Nov 20236530
Dec 20236832
Jan 2024652622
Feb 2024824199
Mar 20245193
Apr 202410046
May 20248749
Jun 202410848
Jul 20247755
Aug 20247849
Sep 20245591
Oct 20247757
Nov 20244438
Back to top
Posted May 20, 2020.
Download PDF
Data/Code
Email
Hydroxychloroquine plus azithromycin: a potential interest in reducing in-hospital morbidity due to COVID-19 pneumonia (HI-ZY-COVID)?
Benjamin Davido, Thibaud Lansaman, Christine Lawrence, Jean-Claude Alvarez, Frédérique Bouchand, Pierre Moine, Véronique Perronne, Aurelie Le Gal, Djillali Annane, Christian Perronne, Pierre De Truchis
medRxiv 2020.05.05.20088757; doi: https://doi.org/10.1101/2020.05.05.20088757
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area